March 28, 2024

Study identifies molecule as potential target for treating AML

While immune checkpoint inhibitors that target the PD-1 molecule on T-cells have proven to be effective with many cancers, these immunotherapies have not worked for acute myeloid leukemia (AML), but new research has identified a “cousin” molecule as a potential therapeutic target for AML. 

By Tom Wilemon

March 27, 2024

New program designed to help patients and families impacted by chronic pain

Psychologists at Monroe Carell Jr. Children’s Hospital at Vanderbilt will soon begin offering a workshop to help patients and families impacted by chronic pain and persistent functional symptoms.

By Jessica Pasley

March 27, 2024

Higher genetic risk of obesity means working out harder for same results 

Study authors used activity, clinical and genetic data from the National Institutes of Health’s All of Us Research Program to explore the association of genetic risk of higher body mass index and the level of physical activity needed to reduce incident obesity. 

By Craig Boerner

March 26, 2024

Vanderbilt Prize winner’s lecture focused on the joy of discovery

During her Discovery Lecture on March 21, Professor Dame Frances Ashcroft, recipient of the 2023 Vanderbilt Prize in Biomedical Science, spoke on the joy science has given her.

By Bill Snyder

March 26, 2024

Keep an eye on safety during April 8 solar eclipse

Eye safety should be a priority when viewing the eclipse on April 8.

By Nancy Humphrey

March 26, 2024

GRADE Study expands results of major NIH-sponsored comparative study of glucose lowering medications in Type 2 diabetes

The study, which included more than 5,000 volunteers with Type 2 diabetes from diverse racial and ethnic groups, compared the treatments insulin glargine, liraglutide, glimepiride and sitagliptin.